Yao Yun and Reporting Group Disband Position in Indaptus Therapeutics, Inc. (INDP)

This Amendment No. 1 to Schedule 13D, filed on April 29, 2026, reflects significant structural changes among the reporting group for Indaptus Therapeutics, Inc. (INDP). The primary purpose of the filing is to announce that the reporting persons—Yun Yao, Sino Lion Ventures Limited, Chenhao Xu, Junyi Dai, Ting Yang, and Lina Deng—have officially disbanded their group and will no longer operate as a collective entity under Section 13(d). Yun Yao remains the largest individual holder with 41,991,000 shares, representing a 37.1% stake, a slight decrease from the previously reported 37.8% due to an increase in the issuer's total outstanding shares. Notably, Lina Deng has ceased to be a beneficial owner of more than 5% of the company's common stock, also resulting from the dilution of shares outstanding. This filing serves as an 'exit filing' for Lina Deng. The shares involved were originally acquired via a Securities Purchase Agreement dated March 19, 2026, following the conversion of Series AA and Series AAA Preferred Stock.